Impact of a CLIA-waived molecular respiratory panel in a pediatric clinic
Project Description: While molecular based respiratory panels have become common and shown benefits in hospital and emergency department settings they are rarely used for outpatients due to the turn-around time, cost, and other factors. More commonly, rapid antigen tests for influenza and respiratory syncytial virus (RSV) are performed, which suffer from limited sensitivity compared with nucleic acid testing. Therefore, the clinical impact of a rapid, point-of-care (POC) diagnostic test for numerous respiratory pathogens is unknown in this setting.
QPI: Stacy, Beal, (email@example.com)
Advisors: Jennifer, Reppucci, (firstname.lastname@example.org); Maira, Gaffar, (email@example.com); Kenneth, Rand, (firstname.lastname@example.org)
UF Health Big Aims: Increase Value None
MeSH Keywords: Anti-Bacterial Agents, Upper Respiratory Infections